FDA Inspection
Grifols Biologicals LLCGrifols Biologicals LLC – FDA Inspection, Aug 24, 2017
Record Details
This FDA Inspection record concerns Grifols Biologicals LLC, with an inspection on August 24, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f25a02a9-3727-4b96-badb-2b0b7d911ebd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1027351
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Grifols Biologicals LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 17, 2026 | Not classified | Los Angeles District Office | Blood and Blood Products |
| May 3, 2024 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 12, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 31, 2019 | Not classified | Los Angeles District Office | |
| October 20, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Grifols Biologicals LLC
- FDA Inspection 1336990 - 2026-09-17
- FDA Inspection 1229139 - 2024-05-03
- FDA Inspection 1105923 - 2019-09-12
- FDA Inspection 1088286 - 2019-01-31
- FDA Inspection 944819 - 2015-10-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.